Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study

Author： Facchinetti Fabio   Allais Gianni   Nappi Rossella E.   Gabellari Ilaria Castagnoli   Di Renzo Gian Carlo   Genazzani Andrea R.   Bellafronte Manuela   Roncolato Maurizio   Benedetto Chiara  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.26, Iss.10, 2010-10, pp. : 773-779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Comparison of Rizatriptan 10 mg vs. Naratriptan 2.5 mg in Migraine

By  

European Neurology, Vol. 42, Iss. 3, 1999-10 ,pp. : 173-179

Karger

Access to resources Recommend Favorite

Comparison of Preference for Rizatriptan 10-mg Wafer versus Sumatriptan 50-mg Tablet in Migraine

By  

European Neurology, Vol. 45, Iss. 4, 2001-05 ,pp. : 275-283

Karger

Access to resources Recommend Favorite

Efficacy of 1,000 mg Effervescent Acetylsalicylic Acid and Sumatriptan in Treating Associated Migraine Symptoms

By  

European Neurology, Vol. 52, Iss. 1, 2004-07 ,pp. : 50-56

Karger

Access to resources Recommend Favorite

Zolmitriptan versus a Combination of Acetylsalicylic Acid and Metoclopramide in the Acute Oral Treatment of Migraine: A Double-Blind, Randomised, Three-Attack Study

By  

European Neurology, Vol. 47, Iss. 2, 2002-02 ,pp. : 88-98

Karger

Access to resources Recommend Favorite

Almotriptan in Migraine Patients Who Respond Poorly to Oral Sumatriptan: A Double-Blind, Randomized Trial

By  

European Neurology, Vol. 53, Iss. 1, 2005-05 ,pp. : 41-48

Karger

Access to resources Recommend Favorite